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Abstract 
In humans, glyoxylate is an intermediary product of metabolism, whose concentration is 
finely balanced. Mutations in peroxisomal alanine:glyoxylate aminotransferase (hAGT1) 
cause primary hyperoxaluria type 1, which results in glyoxylate accumulation that is 
converted to toxic oxalate. In contrast, glyoxylate is used by the nematode C. elegans 
through a glyoxylate cycle to by-pass the decarboxylation steps of the tricarboxylic acid 
cycle and thus contributing to energy production and gluconeogenesis from stored lipids. 
To investigate the differences in glyoxylate metabolism between humans and C. elegans 
and to determine whether the nematode might be a suitable model for PH1, we have 
characterized here the predicted nematode ortholog of hAGT1 (AGXT-1) and compared its 
molecular properties with those of the human enzyme. Both enzymes form active PLP-
dependent dimers with high specificity towards alanine and glyoxylate, and display similar 
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three-dimensional structures. Interestingly, AGXT-1 shows 5-fold higher activity towards 
the alanine/glyoxylate pair than hAGT1. Thermal and chemical stability of AGXT-1 is lower 
than that of hAGT1, suggesting coldtemperature-adaptation of the nematode enzyme 
linked to the lower optimal growth temperature of C. elegans. Remarkably, in vivo 
experiments demonstrate the mitochondrial localization of AGXT-1 in contrast to the 
peroxisomal compartmentalization of hAGT1. Our results support the view that the 
different glyoxylate metabolism in the nematode is associated with the divergent molecular 
properties and subcellular localization of the alanine:glyoxylate aminotransferase activity. 
Keywords. Primary hyperoxaluria; enzyme kinetics; substrate specificity; protein stability; 
conformational disease.  
 
1. Introduction 1 
Glyoxylate is an intermediary product of metabolism in humans, which is formed 2 
from precursors such as glycine, glycolate, hydroxypyruvate and hydroxyproline. Among 3 
mammals, alanine:glyoxylate aminotransferase (AGT) protein compartmentalization is 4 
linked to metabolism of glyoxylate precursors, varying from mainly mitochondrial in 5 
carnivorous, peroxisomal in herbivorous and located in both organelles in omnivorous [1]. 6 
The human AGXT gene encodes an alanine:glyoxylate aminotransferase enzyme (hAGT1; 7 
E.C. 2.6.1.44) that is responsible for glyoxylate detoxification in peroxisomes of 8 
hepatocytes [2] thus balancing the glyoxylate concentration. The human genome encodes 9 
a second protein with alanine:glyoxylate aminotransferase activity named hAGT2 [3] that 10 
catalyses multiple aminotransferase reactions [4,5] and might be involved in the 11 
metabolism of glyoxylate within the mitochondria. hAGT1 is a pyridoxal 5’-phosphate 12 
(PLP)- dependent enzyme that catalyses the amino transfer from L-alanine to glyoxylate 13 
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resulting into pyruvate and glycine and this reaction is largely shifted towards glycine 14 
formation [6]. Mutations in AGXT gene cause primary hyperoxaluria type 1 (PH1), an error 15 
of amino acid metabolism inherited in an autosomal recessive manner [2]. PH1 results in 16 
the accumulation of glyoxylate in hepatocytes where it is oxidized to oxalate (a metabolic-17 
end product in humans) causing progressive renal failure and ultimately leading to a build-18 
up of oxalate and life-threatening oxalate precipitation [2,7]. Currently, the best method to 19 
treat PH1 is a double liver and kidney transplantation, but this treatment often shows 20 
significant rates of morbidity and mortality. 21 
After the complete sequencing of Caenorhabditis elegans genome, early 22 
estimations indicated that around 74% of human gene sequences had nematode 23 
counterparts [8]. Therefore, a lot of effort was put into identifying potential nematode 24 
orthologs to human genes. As a result, using an in silico search of genes associated with 25 
inborn errors of metabolism in humans, an open-reading frame termed as T14D7.1 was 26 
predicted as an ortholog of human AGXT gene [9]. The T14D7.1 gene (now renamed as 27 
agxt-1) is located on chromosome 2 and it is organized into 11 exons 28 
(WBGene00011767), whose conceptual translation results into a 405 amino acids protein 29 
(AGXT-1). Unlike humans, the nematode C. elegans has an active glyoxylate cycle (GC) 30 
[10] that allows to bypass the decarboxylation steps of the tricarboxylic acid (TCA) cycle 31 
[11]⁠, thus linking catabolic and biosynthetic capacities. In the nematode, the key enzyme 32 
of this cycle is a single bi-functional enzyme (ICL-1), which has isocitrate lyase activity (N-33 
terminal domain) and malate synthase activity (C-terminal domain) [12] that are regulated 34 
in a developmentally specific manner [13,14]⁠. 35 
We herein present data supporting that the divergent glyoxylate metabolism 36 
between humans and the nematode C. elegans could be linked toinvolve different 37 
molecular properties and subcellular localization of their respective AGT enzymes. Further, 38 
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we demonstrate that even though AGXT-1 and hAGT1 proteins have similar quaternary 39 
structure and substrate specificities, AGXT-1 displays higher specific activity and lower 40 
protein stability, possibly reflecting cold temperature adaptation of the nematode enzyme. 41 
In vivo studies demonstrate the mitochondrial localization of AGXT-1 in contrast to the 42 
peroxisomal functional environment of hAGT1. In this work, we provide novel insights into 43 
the evolutionary changes in protein stability, roles of AGT proteins and the divergence of 44 
glyoxylate metabolism between vertebrates and invertebrates. 45 
2. Materials and Methods 46 
C. elegans AGXT-1 cloning, expression and purification. The agxt-1 ORF was 47 
amplified from a C. elegans cDNA library and cloned into a pET-28 (Novagen) vector using 48 
the primers ACAGCTAGCATGCAGCCAACAGGGAATCAAATA and TATGTCGACTTAA-49 
ACCAAATTAGGATCCGATGGACTT forward and reverse respectively and restriction 50 
enzymes NheI-HF and SalI-HF (New England Biolabs). This construct incorporates a His-51 
tag sequence at the N-terminal domain of AGXT-1. E. coli BL21(DE3) competent cells 52 
were transformed with the plasmid and were grown in LB medium supplemented with 30 53 
µg·ml-1 kanamycin. Overnight cultures were diluted 40-fold in fresh LB-kanamycin for 3 h 54 
at 37ºC and induced at 4ºC by adding IPTG 0.5 mM for 8 h. Cells were harvested and 55 
lysed by sonication in binding buffer (20 mM NaH2PO4, 200 mM NaCl, 50 mM imidazole, 56 
pH 7.4) supplemented with protease inhibitors (EDTA-free protease inhibitor cocktail, 57 
Roche). Soluble extracts obtained after ultracentrifugation at 70,000 x g were loaded onto 58 
an IMAC columns (GE Healthcare) and eluted with binding buffer supplemented with 500 59 
mM imidazole. His-AGXT-1 was further purified by size exclusion chromatography using a 60 
HiLoadTM 16/60 SuperdexTM 200 column running in 20 mM Hepes (2-[4-(2-61 
hydroxyethyl)piperazin-1-yl]ethanesulfonic acid), 200 mM NaCl, pH 7.4. The concentration 62 
of His-AGXT-1 (hereafter AGXT-1) protein was evaluated using a sequence-based 63 
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extinction coefficient of 0.763 ml·mg-1·cm-1 at 280 nm [15]. The purification of hAGT1 was 64 
performed as described previously [16]. Isolation of apo-forms of both enzymes was 65 
attempted by using the protocol previously described [17]⁠. PLP concentration was 66 
calculated by using a molar extinction coefficient of 4,900 M-1·cm-1 at 388 nm [18]. 67 
Spectroscopic analyses. All the spectroscopic assays were performed in a 20 mM 68 
Hepes, 200 mM NaCl, pH 7.4 buffer at 25ºC. UV-visible absorption spectroscopy was 69 
performed in an Agilent 8453 diode-array spectrophotometer using cuvettes with a path 70 
length of 3 mm and 20 µM protein (in subunit). Near-UV/visible circular dichroism 71 
measurements were performed in a Jasco J-710 spectropolarimeter by using 5-mm path 72 
length cuvettes with 20 µM protein (in subunit). Dynamic light scattering was carried out 73 
using a protein concentration of 5 µM (in subunit) in the presence of 50 µM PLP in a 74 
Zetasizer Nano ZS (Malvern Inc.) with 3-mm path length cuvettes and applying the Stokes-75 
Einstein equation assuming a spherical shape for the scattering particles. 76 
Enzyme activity measurements. The overall transaminase activity was measured at 77 
37ºC with a protein concentration of 2.5 µg·ml-1 in the presence of 150 µM PLP in 0.1 M 78 
phosphate buffer pH 8. The time of the reaction was 2 minutes and the substrate 79 
concentration was 0.25-2 mM glyoxylate and 0-100 mM L-alanine. Pyruvate formation was 80 
evaluated following the oxidation of NADH at 340 nm by a coupled enzyme assay using 81 
lactate dehydrogenase [19] during 3 minutes at 37ºC. Global fittings were performed 82 
according to a double-displacement mechanisms [6,16]. To determine the pH 83 
dependence, activity measurements were performed using this coupled assay in the 84 
presence of 2 mM glyoxylate and 100 mM L-alanine at 37ºC in the following buffers: 100 85 
mM Hepes (pH 7-8), MES (2-(N-morpholino)ethanesulfonic acid, pH 6-6.5), acetate (pH 86 
4.5-5.5) or formiate (pH 3-4). The time of the transamination reaction was set at 1.5 87 
minutes (pH 7-8), 4 minutes (pH 6-6.5) and 10 minutes (pH 3.5-5-5). The dependence of 88 
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specific activity on temperature was measured at 15, 20, 25, 30 and 37ºC with reaction 89 
times from 2 to 10 minutes. To investigate the substrate specificity, the overall 90 
transamination reaction was measured in the presence of different amino acids (L-alanine, 91 
L-serine, L-arginine, L-glutamate, L-aspartate and L-phenylalanine) and ketoacids 92 
(glyoxylate and pyruvate) by incubating the enzymes (2.5-100 µg·ml-1) with the amino acid 93 
at 100 mM, the ketoacid at 2 mM and in the presence of 200 µM PLP in 0.1 M phosphate 94 
buffer, pH 8 and 37ºC. Aliquots of each reaction mixture were collected at various times 95 
and the reaction was stopped by adding 10% (w/v) trichloroacetic acid. The amount of 96 
ketoacid consumed was determined by HPLC after derivatization with 2,4-97 
dinitrophenylhydrazine as previously described [20]. 98 
Differential scanning calorimetry. DSC experiments were performed and analysed as 99 
previously described for hAGT1 [17,21]. Briefly, the model considers the irreversible 100 
denaturation of the native protein to a final state that cannot fold back, and this kinetic 101 
conversion is characterized by a first-order rate constant k, which changes with 102 
temperature according to the Arrhenius equation. The half-life at any temperature can thus 103 
be obtained from extrapolation of k to a given temperature following the Arrhenius plot and 104 
determined as 𝑡1 2⁄ = ln⁡(2) 𝑘⁄ . 105 
Urea denaturation. Urea denaturation of AGXT-1 and hAGT1 was performed by 106 
incubating the enzymes (5 µM in protein subunit) in 20 mM Hepes, 200 mM NaCl, 1mM 107 
TCEP (Tris(2-carboxyethyl)phosphine) pH 7.4 with urea at concentrations ranging from 0-8 108 
M. Urea concentration was determined by refractive index measurements. Samples were 109 
incubated at 25ºC for 16 h and then denaturation was monitored by Far-UV circular 110 
dichroism spectroscopy (200-260 nm; 1 mm quartz cuvettes). Refolding experiments were 111 
performed by dilution of protein samples denatured in 8 M urea solution with urea-free 112 
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buffer and allowed to equilibrate at 25ºC for 4 h prior to Far-UV CD spectroscopic 113 
analyses. 114 
Structural modelling. The structural model of AGXT-1 protein was obtained using the 115 
Modeler v9.13 software, the AGXT-1 amino acids sequence and the crystal structure of 116 
human hAGT1 (pdb 1H0C) protein as a template. The model refinement was performed by 117 
energy minimization applying the CHARM27 force field of the MOE software. The 118 
adjustment of the protonation state, the coordinate based isoelectric point calculation, the 119 
electrostatic surface map drawing, the structural alignment and the images construction 120 
were performed using MOE 2013 software (CCG group).  121 
Strains. C. elegans worms were culture and handle as described before [22]. The 122 
following strains were used: wild type N2 Bristol, UGR1 alpEx1 [Pmyo-3::tomm-20:: gfp, 123 
Pmyo-3::agxt-1(50aa)::tagrfp, Punc-122::gfp], UGR3 alpEx3 [Pmyo-3:: tomm -20:: gfp, 124 
Pmyo-3::agxt-1(100aa):: tagrfp, Punc-122:: gfp] UGR7 alpEx7 [Pmyo-3:: tomm -20:: gfp, 125 
Pmyo-3:: tagrfp, Punc-122:: gfp]. 126 
Molecular biology and transgenic lines. The nucleotide sequence corresponding to the 127 
first 50 and 100 amino acids of the agxt-1 cDNA sequence were amplified and cloned into 128 
a gateway plasmid pDONR221 These clones were fused in frame with tagRFP and the 129 
unc-54 gene 3-UTR and expressed under the myo-3 promoter, using the Multi Site 130 
Gateway Pro Plus Kit (ThermoFisher, catalogue number 11791-100 and 11789-013). 131 
These plasmids were injected at 5 ng·µl-1 together with a plasmid expressing the 132 
mitochondrial fusion construct TOMM-20::GFP under the control of the same myo-3 133 
promoter (kindly provided by Dr. Marc Hammarlund, Yale University) at 5 ng·µl-1 and the 134 
co-injection marker Punc-122::gfp. Transgenic animals were generated using standard 135 
techniques [23]. 136 
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Fluorescence and confocal image acquisition and analysis. Images of fluorescence 137 
fusion proteins were taken in live adults C. elegans nematodes using a 60X CFI Plan Apo 138 
VC, numerical aperture 1.4, oil-immersion objective on an UltraView VoX spinning-disc 139 
confocal microscope (PerkinElmer Life and Analytical Sciences). Worms were 140 
synchronized 3 days prior to experiment, and first day of adulthood animals were 141 
analysed. Animals were immobilized during image acquisition using 10 µM Levamisol 142 
(Sigma). Images were analysed using Volocity software (Improvision). 143 
3. Results 144 
AGXT-1 is a mitochondrial protein. According to a protein sequence comparison, C. 145 
elegans AGXT-1 shows much higher identity/similarity to peroxisomal hAGT1 protein than 146 
to mitochondrial hAGT2, which has a different fold (Table 1). The sequence of AGXT-1 is 147 
13 residues longer than hAGT1 and all catalytic residues involved in the binding and 148 
stabilization of the coenzyme at the active site are conserved in both proteins (Figure 1, 149 
red highlighted residues) [24]. However, we also found two interesting differences between 150 
the two primary sequences (Figure 1, green highlighted residues). First, the 13 extra 151 
residues of AGXT-1 protein are located in the N-terminal domain. Mitochondrial targeting 152 
sequences (MTS) usually consist of 20-60 residues in the N-terminal domain that are 153 
prone to form an amphipathic alpha helix [25]. Bioinformatics tools, such as MitoProt [26] 154 
or TargetP 1.1 Server [27], predict probabilities of 75-85% for the N-terminal domain of 155 
AGXT-1 to form a cleavable amphipathic alpha helix consistent with a potential MTS. 156 
Second, the AGXT-1 protein lacks the C-terminal tripeptide that constitutes the 157 
peroxisomal targeting sequence type 1 (PTS1) required for hAGT1 peroxisomal import 158 
through Pex5p-dependent route [28,29], which is conserved between humans and 159 
nematodes [30]. C. elegans also lacks the alternative PTS2 pathway to target proteins to 160 
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peroxisomes [31]. All together, these data suggest that AGXT-1 is not likely to be imported 161 
to peroxisomes, in contrast to hAGT1 [2], but more likely to be imported to mitochondria. 162 
Table 1. Identity and similarity in pairwise sequence alignments of AGXT-1, hAGT1 
and hAGT2 proteins. Alignments were carried out using Clustal Omega [32]. GI numbers 
of protein sequences are: hAGT1-126522481, hAGT2-119576316 and AGXT-1-5824614. 
Residues hAGT1 vs. hAGT2 AGXT-1 vs. hAGT1 AGXT-1 vs. hAGT2 
Identical 75 (19%) 167 (41%) 77 (19%) 
Similar 112 (28%) 121 (30%) 103 (25%) 
 
Figure 1. Protein sequence comparison between nematode AGXT-1 and human 
hAGT1 protein. AGXT-1 (GI: 5824614) and hAGT1 (GI: 126522481) protein sequence; 
identical residues are marked as (*), similar residues as (:), residues with similar shapes 
as (.) and gaps by (-); residues of the active site are highlighted in red, while gaps in both 
terminal domains are in green. 
In order to confirm this hypothesis, we generated transgenic C. elegans strains 163 
expressing AGXT-1 fused to the N-terminus of tagRFP. Considering that previous studies 164 
have shown the in vivo promoter activity of the agxt-1 gene in muscle cells [33,34] and the 165 
very distinctive mitochondrial tubular pattern of muscle cells [35,36], our construct was 166 
expressed in body wall and vulval muscle cells under the control of the myo-3 promoter. 167 
Unfortunately, expression of the full AGXT-1 fused to tagRFP resulted in big clumps of 168 
fluorescence, reminiscent of aggregation and distorted mitochondria (data not shown). 169 
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This could be a consequence of either a non-proper folding of tagRFP and/or the high 170 
level of expression of the recombinant protein. To avoid this aggregation issue, we 171 
generated additional transgenic strains expressing only the fusion of the N-terminal 172 
sequence of AGXT-1 (containing the putative MTS) with tagRFP. We generated two 173 
different transgenic strains expressing the first 50 and 100 amino acids of AGXT-1 fused in 174 
frame with tagRFP. As mitochondrial marker, we used a transgenic strain expressing a 175 
TOMM-20::GFP fusion protein [37,38]. When tagRFP was expressed alone (Figure 2a), a 176 
diffused cytosolic pattern was seen (Figure 2c), compared with the mitochondrial 177 
localization of TOMM-20::GFP protein (Figure 2b). However, tagRFP fused to either the 178 
first 50 or 100 amino acids of AGXT-1 (Figure 2e-i), was targeted to mitochondria (Figure 179 
2g-k), as demonstrated by the colocalization with TOMM-20::GFP (Figure 2h-l). These 180 
data confirm that the N-terminus of AGXT-1 encodes a functional MTS, thus reinforcing 181 
the idea of AGXT-1 being a mitochondrial enzyme in C. elegans. 182 
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Figure 2. Mitochondrial localization of AGXT-1. Cartoons representing the DNA 
constructs used to express tagRFP (a), the first 50 amino acids (e) and the first 100 amino 
acids (i) of AGXT-1 fused to tagRFP under the control of the myo-3 promoter along with 
the unc-54 3’-UTR. TOMM-20::GFP expression is found with the typical tubular 
mitochondrial pattern in muscle cells (b, f and j). When tagRFP is expressed alone, a 
diffused cytosolic pattern is seen (c) and no colocalization is found with TOMM-20::GFP 
(d, merge). Fusing the first N-terminal 50 (MTS50) (g) or 100 (MTS100) (k) amino acids of 
the AGXT-1 to tagRFP targets the protein to mitochondria. The GFP and tagRFP 
fluorescence now colocalize to the same organelle (h and l, merge). 
 
AGXT-1 and hAGT1 share overall structure. Taking into account the considerable 183 
sequence homology between AGXT-1 and hAGT1, we built a structural homology model 184 
of AGXT-1 using the available crystal structure of hAGT1 as a template [24]. Due to the 185 
high flexibility of the N-terminus of hAGT1 and substantial sequence differences between 186 
the N-terminal domains of both proteins (Figure 1), we did not include in the structural 187 
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alignment the first 38 and 23 amino acids of AGXT-1 and hAGT1, respectively. The AGXT-188 
1 model was subsequently refined by energy minimization. The superposition of the 189 
obtained AGXT-1 model and the hAGT1 structure predicts that the two proteins share a 190 
similar overall conformation and secondary structure composition (Figure 3a). The binding 191 
mode of PLP to AGXT-1 protein appears to be very similar to that of the human enzyme 192 
and involves a Schiff base linkage with Lys226, a base stacking hydrophobic interaction 193 
between the pyridine ring and the side chain of Trp125, a salt bridge between the N1 of 194 
PLP and Asp200, an H-bond of the 3'OH group of PLP and Ser175 and several H-bonds 195 
between the phosphate group of the coenzyme and Gln225, Gly99 and His100 (Figure 196 
3b). Moreover, two interchain contacts of the phosphate group of PLP in hAGT1 with 197 
Tyr260 and Thr263 of the neighbouring subunit, are probably held by Tyr277 and Thr280 198 
in AGXT-1. 199 
However, some differences are visible in the active site region and on the protein 200 
surface. As for the active site cleft, Ser81 that in hAGT1 is critical for PLP binding [39] is 201 
replaced by a threonine residue (Thr98) in AGXT-1. Moreover, Arg360, whose side chain 202 
binds the carboxylate group of the substrate in hAGT1 [24], is replaced by Ile377 in AGXT-203 
1 (Figure 3c), thus leading to a different active site polarity and possibly a different 204 
substrate binding mode. In addition, Trp246 and Met259 of hAGT1 are replaced by Glu263 205 
and Arg276 in AGXT-1. As shown in Figure 3d, these two charged residues could interact 206 
by a salt bridge, thus probably stabilizing the interface loop 276-282 comprising the 207 
aforementioned Tyr277 and Thr280 residues involved in the binding of the coenzyme. 208 
Electrostatic surface map calculations revealed that AGXT-1 would exhibit a higher density 209 
and a different distribution of the surface charges with respect to hAGT1 (not shown). 210 
 
 
13 
 
Figure 3. Structural alignment of the AGXT-1 model with the hAGT1 structure. 
Structural over imposition of AGXT-1 (orange) and hAGT1 (grey). The two backbones are 
represented as ribbons and the single residues as sticks. The PLP molecule is 
represented as green sticks. 
 
AGXT-1 is a dimeric PLP-dependent alanine:glyoxylate aminotransferase. To 211 
compare the molecular properties of AGXT-1 and hAGT1, both recombinant proteins were 212 
expressed in and purified from E. coli. Along protein purification, size-exclusion 213 
chromatography analyses showed a single peak with similar retention volumes for both 214 
proteins and attributable to a dimer (82.6 ml and 84.9 ml in a SuperdexTM 200 16/60 for 215 
hAGT1 and AGXT-1, respectively). Dynamic light scattering studies also revealed similar 216 
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hydrodynamic diameters for both proteins (8.1±0.1 nm vs. 8.8±0.4 nm, for hAGT1 and 217 
AGXT-1, respectively), thus further confirming the dimeric assembly of the two proteins 218 
[16,40]. As isolated, both proteins show spectroscopic features corresponding to PLP 219 
bound to the active site by a Schiff base with Lys209 in hAGT1 and Lys226 in AGXT-1. 220 
The UV-visible absorption and CD spectra of AGXT-1 display a band at 430 nm, which 221 
likely reflects the ketoenamine tautomer of the internal Schiff base, and a band at 340 nm, 222 
possibly corresponding to enolimine tautomer (Figure 4 and [6]). After incubation of AGXT-223 
1 with L-alanine, the spectra show almost no signal at 430 nm and a main absorption peak 224 
and weak dichroic band at 340 nm (Figure 4). These signals indicate the formation of the 225 
pyridoxamine-5'-phosphate (PMP) form of the coenzyme, thus supporting the proper 226 
binding of PLP in the active site of AGXT-1 to take the amino group from the substrate L-227 
alanine. Attempts to remove the coenzyme from the active site of AGXT-1 (to obtain the 228 
apo-form) by using the procedure applied for hAGT1 [16,17]⁠ yielded a form of AGXT-1 229 
with PMP tightly bound, suggesting a very high affinity and/or very slow dissociation rate of 230 
PMP. Further reduction of the pH (below 5.8) resulted in irreversible denaturation of 231 
AGXT-1 before the release of the coenzyme, thus preventing a comparison between the 232 
apo-form of AGXT-1 and hAGT1. Together, these results suggest that AGXT-1 binds PMP 233 
with higher affinity than hAGT1 and/or that the pH value for efficient PMP release is lower 234 
for AGXT-1. 235 
Next, the ability of AGXT-1 to catalyse the amino transfer by using the natural 236 
substrates of hAGT1 (L-alanine and glyoxylate) was tested (Figure 5). Activity data were 237 
analysed by using a coupled enzyme assay as described for hAGT1 [6,16]. Kinetic 238 
parameters for the overall transamination show that AGXT-1 has 5-fold higher activity 239 
(Vmax) than hAGT1 (Table 2), while apparent affinities (KM) for both substrates are kept in 240 
similar ranges. Only the apparent affinity for L-alanine is slightly higher (1.6-fold higher) for 241 
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AGXT-1 than for hAGT1. These results support a higher catalytic efficiency towards 242 
glyoxylate for the nematode enzyme than for the hAGT1. In addition, both proteins show 243 
similar dependence of the overall transaminase activity on temperature and pH (Figure 6). 244 
Arrhenius analyses of temperature dependence of transaminase activity reveal an 245 
activation energy value of 4.0±0.9 kcal·mol-1 for AGXT-1, somewhat higher than for 246 
hAGT1 (2.2±1.8 kcal·mol-1) (Figure 6a). The activity of both enzymes decreases at mild 247 
acidic pH (Figure 6b-c), suggesting similar pattern of protonation states of the active site of 248 
both proteins, which could be a sign of similar reaction specificities [41] and environmental 249 
pH in their intracellular localization [42]. 250 
 
Figure 4. Near-UV/visible spectroscopic analyses of AGXT-1 and hAGT1 in their PLP-
bound forms and in the presence of 0.5 M L-alanine (PMP-forms). (a) Near-UV/visible 
absorption spectra; (b) Near UV/visible circular dichroism spectra; Protein concentration 
was 20 μM in monomer. 
 
 
 
 
Table 2. Kinetic parameters of the overall transaminase activity for AGXT-1 and 
hAGT1. Data are mean±s.d. from global fits from a coupled enzyme assay. 
Parameter AGXT-1 hAGT1 
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Vmax (mmol·h
-1·mg-1) 11.3±0.7 2.2±0.1 
KM,alanine (mM) 12±2 20±2 
KM,glyoxylate (mM) 0.26±0.05 0.26±0.04 
 
Figure 5. Enzyme kinetic analyses of AGXT-1 (a) and hAGT1 (b) proteins in the 
presence of L-alanine and glyoxylate. Experiments were performed at 0.25 mM (closed 
circles) and 2 mM (open circles) glyoxylate and varying L-alanine concentrations. Lines 
are global best-fits to an enzyme-substituted kinetic mechanism yielding the kinetic 
parameters shown in Table 2. 
 
The large difference in activity between AGXT-1 and hAGT1 towards the 251 
alanine:glyoxylate pair prompted us to investigate whether these two enzymes may share 252 
similar substrate specificity [6]⁠. To this aim, we determined the specific activity of these 253 
enzymes by using glyoxylate or pyruvate as amino acceptors and different natural L-amino 254 
acids as amino donors (Figure 7). When using glyoxylate as amino acceptor, AGXT-1 255 
protein is very specific towards L-alanine showing 300-fold and 130-fold higher activity 256 
than for L-serine and L-phenylalanine and no detectable activity towards L-arginine, L-257 
glutamate and L-aspartate (Figure 7a). Under similar conditions, hAGT1 is somewhat less 258 
specific, with 23-fold and 52-fold lower activity towards L-serine and L-arginine and 100-259 
fold and 200-fold lower activity towards L-phenylalanine and L-glutamate (Figure 7a). 260 
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Using pyruvate as amino acceptor (Figure 7b), both enzymes display lower activity 261 
towards L-serine than those measured using glyoxylate. Their activities towards L-262 
phenylalanine are comparable, L-arginine is a better substrate for hAGT1 than AGXT-1 263 
and L-glutamate and L-aspartate are poor substrates for both enzymes. Even though 264 
some differences exist, these studies support similar substrate specificities for both 265 
proteins and demonstrate that AGXT-1 protein is an alanine:glyoxylate aminotransferase. 266 
 
Figure 6. Temperature- and pH-dependence of the overall transaminase activity for 
AGXT-1 and hAGT1 proteins. (a) Arrhenius plots for the enzymatic activity of AGXT-1 
and hAGT1; (b) and (c) pH-dependence of the enzymatic activity of hAGT1 and AGXT-1, 
respectively. Activity was measured in the presence of 100 mM L-alanine and 2 mM 
glyoxylate. 
 
 
18 
 
Figure 7. Substrate specificity of AGXT-1 and hAGT1 towards different amino acids 
as amino donor using glyoxylate (a) or pyruvate (b) as amino acceptors. The 
concentration of amino acids was 100 mM and of ketoacids was 2 mM. N.Det.- not 
detected. 
 
AGXT-1 shows lower resistance towards thermal and chemical denaturation. 267 
Thermal denaturation of AGXT-1 was studied by differential scanning calorimetry (DSC). 268 
Both AGXT-1 and hAGT1 show a single denaturation transition (Figure 8a), which is well 269 
described by a simple two-state irreversible denaturation model with first-order kinetics 270 
(supported by protein concentration independent denaturation transitions [16,17] and data 271 
not shown). The denaturation temperature (Tm) of AGXT-1 is about 12ºC lower than that of 272 
hAGT1 (Table 3). The lower denaturation enthalpy (∆H) of AGXT-1 seems to be a 273 
consequence of the lower thermal stability of this protein and a strongly temperature 274 
dependent ∆H with a theoretical denaturation heat capacity of about 11 kcal·mol-1·K-1 275 
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(based on the correlations by [43]), thus suggesting that the amount of tertiary structure 276 
lost upon thermal denaturation in both enzymes is fairly similar. Due to the kinetic control 277 
of thermal denaturation for both enzymes, the DSC analyses can be used to extrapolate 278 
the denaturation rate constants to physiological temperatures (inset Figure 8a). The 279 
extrapolated kinetic stability for AGXT-1 towards thermal denaturation at 37ºC is around 280 
200-fold lower than hAGT1 at this temperature (Table 3). However, when we compare the 281 
kinetic stability of both proteins at the corresponding physiological temperature (37ºC for 282 
hAGT1 and 20ºC for AGXT-1) the nematode protein is 90-fold more stable than hAGT1. 283 
Table 3. Thermal denaturation parameters for AGXT-1 and hAGT1. The parameters 
have been determined from DSC scans using a two-state irreversible denaturation model. 
1 Data from Mesa-Torres, PLoS One, 2013. 2 Determined at 3ºC·min-1 scan rate. 3 
mean±s.d. from three different scan rates. 4 kinetic constant rates for irreversible 
denaturation extrapolated to 37ºC (20ºC) 
Parameter AGXT-1 hAGT1 1 
Tm (ºC) 
2 69.8 82.1 
∆H (kcal·mol-1) 3 366±11 548±5 
Ea (kcal·mol
-1) 3 112±15 109±5 
k37ºC (k20ºC) (min
-1) 4 1.2·10-7 (7.1·10-12)  6.4·10-10 
 
Urea induced denaturation of AGXT-1 was investigated by Far-UV circular 284 
dichroism spectroscopy (Figure 8b). Denaturation profiles of AGXT-1 and hAGT1 show a 285 
single transition and once again, AGXT-1 displays a lower stability with half-denaturation 286 
urea concentration of ∼3.8 M (AGXT-1) vs. ∼6 M (hAGT1). The cooperativity of urea-287 
induced unfolding is apparently higher for AGXT-1 than for hAGT1. In contrast to hAGT1 288 
([44] and data not shown), urea unfolding of AGXT-1 is highly reversible (Figure 8b 289 
squares). indicating This reversibility suggests that,  along the refolding pathway of AGXT-290 
1 upon chemical denaturation, the refolding pathway of AGXT-1 populates less population 291 
of aggregation-prone intermediate statess is much lower. 292 
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Figure 8. Stability of AGXT-1 and hAGT1 proteins towards thermal and chemical 
denaturation. (a) Thermal denaturation profiles of holo AGXT-1 and hAGT1 at 3ºC·min-1 
and 5 μM protein subunit in 20 mM Na-Hepes, 200 mM NaCl pH 7.4. Lines are best-fits to 
a two-state irreversible model with first-order kinetics; Inset: Arrhenius plots for thermal 
denaturation kinetics; (b) Urea-induced unfolding of holo AGXT-1 and hAGT1 at 5 μM 
protein subunit in 20 mM Na-Hepes, 200 mM NaCl pH 7.4, 1 mM TCEP at 25ºC. Circles 
show the results for unfolding, while squares correspond to refolding experiments. 
 
4. Discussion 293 
Glyoxylate is a metabolic intermediary in humans that has to be detoxified mainly by 294 
hAGT1 in peroxisomes [2]. Instead, glyoxylate is a key metabolite in C. elegans due to the 295 
presence of an active glyoxylate cycle [10,12]⁠. The sequencing of C. elegans genome 296 
predicted a putative ortholog of human AGXT gene in the nematode (ORF T14D7.1, [9] 297 
now renamed to agxt-1⁠). However, the molecular properties of the protein product of 298 
agxt-1 gene have not been previously investigated. Here, we have performed a side-by-299 
side comparative study on the molecular properties of AGXT-1 protein in comparison with 300 
human hAGT1, showing that AGXT-1 is a functional PLP-dependent enzyme with 301 
aminotransferase activity and a higher activity and specificity towards the 302 
alanine:glyxoxylate pair than hAGT1. Our results also support that both enzymes are 303 
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structurally and functionally alike, but show different protein stability and subcellular 304 
localization, where AGXT-1 is mitochondrial whereas and hAGT1 is peroxisomal. 305 
The mitochondrial localization of AGXT-1 provides important insights into the 306 
evolutionary adaptation of AGTs subcellular compartmentalization, and possibly, into its 307 
relation with dietary origins of glyoxylate and the molecular origin of mitochondrial 308 
mistargeting in PH1. AGT subcellular localization has represented a remarkable 309 
conundrum for cell and evolutionary biologists and molecular pathologists. The AGTs 310 
peroxisomal localization is attributed to a PTS1 located at the C-terminal domain, while the 311 
mitochondrial localization is mainly controlled by the activation of a cryptic MTS in the N-312 
terminal domain that overrides the PTS1 route [1]. Therefore, the AGXT gene seems to 313 
have evolved to meet dietary requirements, with alternative translation and transcription 314 
sites to allow the protein to contain this strong MTS sequence [45]. In most omnivorous 315 
mammals the AGT enzyme is distributed in mitochondria or peroxisomes, based on the 316 
presence or absence of the MTS, respectively. In carnivorous mammals, the AGT 317 
localization is mainly mitochondrial while a selective lost loss of the MTS is found in 318 
herbivorous animals [46]. These evolutionary changes in subcellular distribution of AGT 319 
associated with dietary changes have been recently exemplified by sequencing and 320 
evolutionary analyses on different bat species with unparalleled dietary diversification [47]. 321 
Importantly, hAGT1 contains a very weak MTS, which becomes stronger in the presence 322 
of the destabilizing P11L polymorphism and certain pathogenic mutations, that result into 323 
mitochondrial mistargeting [16,48]. Unlike the behaviour found along evolution, which 324 
seems to define the subcellular targeting of AGT using relatively simple transcriptional and 325 
translational mechanisms, mitochondrial mistargeting of hAGT1 seems to depend strongly 326 
on the cellular context. For instance, a given single genotype may lead or not to 327 
mitochondrial import depending on the cell type and culture conditions [16,49,50] 328 
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highlighting the important role of molecular chaperones and/or other factors of the protein 329 
homeostasis network in the final fate of hAGT1 disease-causing variants [16,17]. 330 
Along evolution, enzyme properties are selected to provide appropriate metabolic 331 
rates at different physiological temperatures by tuning some structure-function 332 
relationships i.e., stability, enzyme activity and ligand affinity [51]. While the physiological 333 
temperature of humans is kept constant at 37ºC, the nematode C. elegans is an ectotherm 334 
organism that can survive between 8-27ºC and whose physiology is highly affected by the 335 
environmental temperature. The lower denaturation temperature and high catalytic activity 336 
of AGXT-1 likely reflects coldtemperature-adaptation [52]. Moreover, the similar apparent 337 
affinities for natural substrates of hAGT1 displayed by AGXT-1, suggest resemblance in 338 
substrate concentration or KM:[substrate] ratio, at their respective organelles [53]⁠. It must 339 
be noted that the activity and intracellular turnover of hAGT1 must be tuned to be 340 
appropriate at a customarily constant temperature of 37ºC, while the conformational 341 
stability of AGXT-1 seems to be adapted to lower temperatures. These results may 342 
indicate that the overall stability of different AGT orthologs is optimized to provide an 343 
adequate intracellular turnover at optimal growth temperature, which in the case of hAGT1 344 
is severely compromised by disease-associated mutations leading to protein misfolding 345 
and mistargeting [2,16,40,54]. 346 
The main biological function of hAGT1 is to create a glyoxylate sink in peroxisomes of 347 
of hepatocytes. In addition, there is a set of proteins that contribute to this human 348 
glyoxylate metabolism. According to KEGG (Kyoto Encyclopedia of Genes and Genomes) 349 
and REACTOME Pathway Database, these proteins are D-amino acid oxidase (hDAO), 350 
hydroxyacid oxidase (hHAO), glyoxylate reductase / hydroxypyruvate reductase 351 
(hGRHPR), D-4-hydroxy-2-oxoglutarate aldolase (hHOGA1), alanine:glyoxylate 352 
aminotransferase 2 (hAGT2) and lactate dehydrogenase (hLDH) (Figure 9). Despite the 353 
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key role of glyoxylate cycle in C. elegans [55] (Figure 9), surprisingly the genome of the 354 
nematode encodes orthologous proteins to those already described for the human 355 
glyoxylate metabolism, with the only exception of mitochondrial hHOGA1 protein ( 356 
  
 
 
24 
 
Table 4Table 4). Therefore the main routes of glyoxylate metabolism in humans are 357 
expected to work in the nematode, at least to some extent. Some phenotypes have been 358 
described by large-scale gene downregulation in C. elegans, such as the association of 359 
C31C9.2 (ortholog of hGRHPR) [9] with low embryonic lethality [56] and slow growing [57], 360 
or⁠ T09B4.8 (ortholog of hAGT2) linked to a reduction of fat content [58]. However, 361 
according to the WormBase Consortium (www.wormbase.org - WS249) no altered 362 
lethality, fertility or development has been described to the lack of function of AGXT-1, 363 
F41E6.5 (ortholog of hDAO), DAAO1 and LDH-1 proteins. This suggests that the steps of 364 
glyoxylate metabolism that are catalysed by these enzymes may not be essential for the 365 
normal development and metabolism of the nematode. Nonetheless, the relative 366 
contributions of these enzymes to different biochemical pathways requires knowledge on 367 
their enzymatic properties and regulation, expression levels and metabolic fluxes, which 368 
can be developmental and environmental dependent [59]. Alternatively, there are no 369 
orthologous proteins in humans to the key C. elegans enzyme ICL-1, although a human 370 
malate synthase activity has been detected with unknown biological function [60]. 371 
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Figure 9. Main routes of glyoxylate metabolism in human hepatocytes and nematode 
body wall muscle cells. AGT: alanine:glyoxylate aminotransferase, DAO: D-amino acid 
oxidase, HAO1: hydroxyacid oxidase, GRHPR: glyoxylate reductase / hydroxypyruvate 
reductase, HOGA1: D-4-hydroxy-2-oxoglutarate aldolase, AGT2: alanine:glyoxylate 
aminotransferase 2, LDH: lactate dehydrogenase and ICL-1: bi-functional isocitrate 
lyase:malate synthase. 
 
In C. elegans, GC supports gluconeogenesis by incorporating acetyl-CoA (particularly from 372 
ß-oxidation of fatty acids in peroxisome and mitochondria) and supplying succinate to TCA 373 
cycle and malate to the gluconeogenesis pathway [13,14]. The GC activity is increased 374 
during embryogenesis, L1 larvae and dauer diapause, while TCA cycle is increased in the 375 
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L2, L3 and L4 stages, when energy demands and food intake are increased [14]. The GC 376 
and TCA cycles share some enzymatic activities (malate dehydrogenase, citrate synthase 377 
and aconitase), while some enzymes, ICL-1 (GC) and isocitrate dehydrogenase (TCA), 378 
compete for the same substrate (isocitrate). Therefore the relative activity of these 379 
enzymes controls the ratio carbon flux through both cycles (GC and TCA) [55]. Unlike 380 
other nematodes [61], evidence suggests that key enzymes of GC in C. elegans are 381 
separable from mitochondria markers and may be compartmentalized in glyoxysome-like 382 
microbodies [62]⁠. This physical separation of GC and TCA enzymes may imply either the 383 
existence of isoforms of those shared enzymes activities in glyoxysomes or the 384 
transportation of metabolites (e.g., isocitrate and succinate) across organelles membranes 385 
[63], which may function as a metabolic regulatory mechanism [64]. The existence of a 386 
highly active alanine:glyoxylate aminotransferase (AGXT-1) in the mitochondria of the 387 
nematode could avoid the competition with ICL-1 enzyme for the substrate glyoxylate. The 388 
transamination of glyoxylate into glycine could provide a way to modulate levels of 389 
glyoxylate in mitochondria, which would otherwise be toxic and may affect the regulation of 390 
the TCA cycle by inhibiting enzymes such as ketoglutarate dehydrogenase [65]. In 391 
humans, the hAGT1 activity is known to act in the detoxification of glyoxylate within 392 
peroxisomes of hepatocytes, while the presence of an active glyoxylate cycle in the 393 
nematode opens the possibility of alternative metabolic roles for the AGXT-1 protein. To 394 
further characterize the role of AGXT-1 on different metabolic pathways and 395 
developmental conditions, combined RNAi downregulation of both agxt-1 and icl-1 genes 396 
as well as the generation of agxt-1;icl-1 double mutant with analyses of metabolites in C. 397 
elegans cultures should be approached. 398 
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Table 4. Orthologous proteins in C. elegans found from a BLASTP of human 
proteins involved in glyoxylate metabolism. GI numbers of protein sequence used are: 
hAGT- 126522481; hDAO- 148539837; hHAO- 11068137; hGRHPR- 6912396; hHOGA- 
31543060; hAGT2- 119576316; hLDH- 32693754. n/a, not available. 
H. sapiens C. elegans 
Protein Residues Localization Protein Residues Identity E value 
hAGT 392 Perox. AGXT-1 405 44% 5·10-115 
hDAO 347 Perox. DAAO1 322 35% 8·10-61 
hHAO 370 Perox. F41E6.5b 371 46% 6·10-115 
hGRHPR 328 Perox./Cyt. C31C9.2 322 30% 1·10-29 
hHOGA 327 Mito. Not found n/a n/a n/a 
hAGT2 514 Mito. T09B4.8 444 53% 1·10-165 
hLDH 332 Cyt. LDH-1 333 54% 6·10-119 
 
C. elegans is a remarkably useful model system to understand protein folding 399 
diseases and their pharmacological correction [66–68]. Our studies pave the way to 400 
develop suitable models for PH1 using C. elegans. To generate them, it will be important 401 
to determine whether simultaneous inactivation of agxt-1 gene and the malate synthase 402 
domain of ICL-1 make the nematodes susceptible to glyoxylate toxicity, similarly to what is 403 
found in humans with hAGT1 deficiency. Alternatively, models expressing disease-404 
associated variants of hAGT1 in C. elegans may also provide a convenient in vivo platform 405 
to explore and dissect the complex protein homeostasis defects associated with PH1-406 
causing mutations. 407 
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